[SCIENTX] YoY TTM Result on 31-Oct-2022 [#1]

Stock
[SCIENTX] SCIENTEX BERHAD
Announcement Date
08-Dec-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2023
Quarter
31-Oct-2022 [#1]
Profit Trend
QoQ- 1.05%
YoY- -11.42%
Quarter Report
Latest QR
Upcoming QR
SCIENTX's Result
SCIENTX's Financial Summary
View:
Show?
TTM Result
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Revenue 4,153,524 4,087,022 3,781,879 3,443,495 3,411,172 2,681,724 2,527,149 8.62%
PBT 616,701 554,595 603,350 556,448 493,894 341,630 344,121 10.20%
Tax -138,721 -116,784 -109,263 -125,980 -115,881 -65,649 -63,772 13.82%
NP 477,980 437,811 494,087 430,468 378,013 275,981 280,349 9.29%
-
NP to SH 468,807 414,175 467,574 401,685 360,993 271,070 276,218 9.21%
-
Tax Rate 22.49% 21.06% 18.11% 22.64% 23.46% 19.22% 18.53% -
Total Cost 3,675,544 3,649,211 3,287,792 3,013,027 3,033,159 2,405,743 2,246,800 8.54%
-
Net Worth 3,536,425 3,226,079 2,930,741 2,658,038 2,308,371 1,823,695 1,605,708 14.05%
Dividend
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Div 155,106 139,589 139,554 118,651 102,457 97,785 75,852 12.65%
Div Payout % 33.09% 33.70% 29.85% 29.54% 28.38% 36.07% 27.46% -
Equity
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Net Worth 3,536,425 3,226,079 2,930,741 2,658,038 2,308,371 1,823,695 1,605,708 14.05%
NOSH 1,551,063 1,550,999 1,550,656 516,864 515,261 488,926 483,647 21.42%
Ratio Analysis
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
NP Margin 11.51% 10.71% 13.06% 12.50% 11.08% 10.29% 11.09% -
ROE 13.26% 12.84% 15.95% 15.11% 15.64% 14.86% 17.20% -
Per Share
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
RPS 267.79 263.51 243.89 667.18 662.03 548.49 522.52 -10.53%
EPS 30.22 26.70 30.15 77.83 70.06 55.44 57.11 -10.06%
DPS 10.00 9.00 9.00 23.00 19.88 20.00 15.68 -7.21%
NAPS 2.28 2.08 1.89 5.15 4.48 3.73 3.32 -6.06%
Adjusted Per Share Value based on latest NOSH - 1,550,999
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
RPS 266.89 262.62 243.01 221.27 219.19 172.32 162.39 8.62%
EPS 30.12 26.61 30.04 25.81 23.20 17.42 17.75 9.20%
DPS 9.97 8.97 8.97 7.62 6.58 6.28 4.87 12.67%
NAPS 2.2724 2.073 1.8832 1.708 1.4833 1.1718 1.0318 14.05%
Price Multiplier on Financial Quarter End Date
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Date 31/10/23 31/10/22 29/10/21 30/10/20 31/10/19 31/10/18 31/10/17 -
Price 3.65 3.26 4.66 11.88 9.20 8.59 8.90 -
P/RPS 1.36 1.24 1.91 1.78 1.39 1.57 1.70 -3.64%
P/EPS 12.08 12.21 15.45 15.26 13.13 15.49 15.58 -4.15%
EY 8.28 8.19 6.47 6.55 7.62 6.45 6.42 4.32%
DY 2.74 2.76 1.93 1.94 2.16 2.33 1.76 7.65%
P/NAPS 1.60 1.57 2.47 2.31 2.05 2.30 2.68 -8.23%
Price Multiplier on Announcement Date
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Date 14/12/23 08/12/22 08/12/21 17/12/20 17/12/19 28/12/18 06/12/17 -
Price 3.60 3.40 4.58 12.02 9.53 9.15 8.58 -
P/RPS 1.34 1.29 1.88 1.80 1.44 1.67 1.64 -3.30%
P/EPS 11.91 12.73 15.19 15.44 13.60 16.50 15.02 -3.79%
EY 8.40 7.85 6.58 6.47 7.35 6.06 6.66 3.94%
DY 2.78 2.65 1.97 1.91 2.09 2.19 1.83 7.21%
P/NAPS 1.58 1.63 2.42 2.33 2.13 2.45 2.58 -7.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment